cas 1251619-21-2|| where to buy 1-(3,5-dimethoxyphenyl)-6-ethoxy-3-(1,2,3,4-tetrahydroisoquinoline-2-carbonyl)-1,4-dihydropyridazin-4-one

Nombre del producto:1-(3,5-dimethoxyphenyl)-6-ethoxy-3-(1,2,3,4-tetrahydroisoquinoline-2-carbonyl)-1,4-dihydropyridazin-4-one

IUPAC Name:1-(3,5-dimethoxyphenyl)-6-ethoxy-3-(1,2,3,4-tetrahydroisoquinoline-2-carbonyl)-1,4-dihydropyridazin-4-one

Unidad de embalaje	Stock disponible	Precio($)	Cantidad

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1251619-21-2 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :1251619-21-2; Fórmula molecular:C24H25N3O5; Punto de fusión:-; Código de sonrisas:CCOC1=CC(=O)C(=NN1C1=CC(OC)=CC(OC)=C1)C(=O)N1CCC2=C(C1)C=CC=C2; Densidad:

: Número de catálogo:CM790730; Peso molecular:435.48; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Pyridazines; Pyridazine, also known as o-diazobenzene, is a six-membered heterocyclic compound containing two nitrogen heteroatoms in the 1 and 2 positions with a special structure and a wide biological activity. Pyridazine is more and more popular in drug development, and a variety of pyridazine drugs have been developed and marketed. From the perspective of the therapeutic field, pyridazine drug molecules are mainly used for tumor treatment, but also involve in many therapeutic fields such as inflammation, hypertension and cardiovascular disease. With the increase and in-depth of research, pyridazine drugs will play more roles in the treatment of diseases.

: Tetrahydroisoquinolines; Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.